A Preadipocyte Differentiation Assay as a Method for Screening Potential Anti-Type II Diabetes Drugs from Herbal Extracts

Authors:
  • SXShang-Zhi Xiao
    Shang-Zhi Xiao
  • YSYong-Hong Sun
    Yong-Hong Sun
  • YOYang Ou-Yang
    Yang Ou-Yang
  • CGChen Guan
    Chen Guan
  • XZXiao-Xiang Zheng
    Xiao-Xiang Zheng

Abstract
A cell-based method for screening drug candidates from herbal extracts that have possible anti-type II diabetic effects was established. The differentiation of preadipocytes into adipocytes was used as a sensitive primary indicator of a drug’s potential effect on type II diabetes. We established a quantitative method by using a computer image analysis system for assessing the morphological alterations. The assay was validated by screening compounds extracted from Chinese herbs and the known drug rosiglitazone for their capability of modulating PPARγ gene expression and glucose uptake by adipocytes. Two drug candidates having possible anti-type II diabetic effects were identified. DMEM:Dulbecco's modified Eagle's medium FCS:fetal calf serum RT-PCR:reverse transcriptase-polymerase chain reaction WST:water-soluble tetrazolium PPARγ:peroxisome proliferator-activated receptor FITC:fluorescein isothiocyanate PI:propidium iodide PS:phosphatidyl serine